loadpatents
name:-0.045793056488037
name:-0.042460918426514
name:-0.0067451000213623
Ujjainwalla; Feroze Patent Filings

Ujjainwalla; Feroze

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ujjainwalla; Feroze.The latest application filed is for "substituted tetrahydroisoquinoline compounds useful as gpr120 agonists".

Company Profile
6.38.34
  • Ujjainwalla; Feroze - Hoboken NJ
  • Ujjainwalla; Feroze - Kenilworth NJ
  • Ujjainwalla; Feroze - Ridgewood NJ
  • Ujjainwalla; Feroze - Scotch Plains NJ US
  • Ujjainwalla; Feroze - Rahway NJ
  • Ujjainwalla; Feroze - Edison NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists
Grant 11,161,819 - Adams , et al. November 2, 2
2021-11-02
Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists
App 20200347020 - Adams; Gregory L. ;   et al.
2020-11-05
Tricyclic compounds as inhibitors of mutant IDH enzymes
Grant 10,508,108 - Fischer , et al. Dec
2019-12-17
Tricyclic compounds as inhibitors of mutant IDH enzymes
Grant 10,442,819 - Fischer , et al. Oc
2019-10-15
Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists
App 20190161448 - Adams; Gregory L. ;   et al.
2019-05-30
Tricyclic compounds as inhibitors of mutant IDH enzymes
Grant 10,086,000 - Fischer , et al. October 2, 2
2018-10-02
Isoquinoline derivatives as MGAT2 inhibitors
Grant 10,065,945 - Berger , et al. September 4, 2
2018-09-04
Isoquinoline Derivatives As Mgat2 Inhibitors
App 20180009796 - Berger; Richard ;   et al.
2018-01-11
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes
App 20170369507 - Christian; Fischer ;   et al.
2017-12-28
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes
App 20170360800 - Fischer; Christian ;   et al.
2017-12-21
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes
App 20170362220 - Fischer; Christian ;   et al.
2017-12-21
Platelet-activating factor receptor antagonists
Grant 9,029,377 - Ogawa , et al. May 12, 2
2015-05-12
Spiroxazolidinone compounds
Grant 8,742,110 - Duffy , et al. June 3, 2
2014-06-03
Diphenyl substituted alkanes as flap inhibitors
Grant 8,729,104 - Chu , et al. May 20, 2
2014-05-20
Benzimidazole and aza-benzimidazole carboxamides
Grant 8,470,819 - Chu , et al. June 25, 2
2013-06-25
Spiroxazolidinone Compounds
App 20130131042 - Duffy; Joseph L. ;   et al.
2013-05-23
Diphenyl substituted alkanes
Grant 8,440,672 - Ogawa , et al. May 14, 2
2013-05-14
Diaryl substituted alkanes
Grant 8,426,413 - Chu , et al. April 23, 2
2013-04-23
Biaryl carboxamides
Grant 8,367,679 - Ogawa , et al. February 5, 2
2013-02-05
Diaryl Substituted Alkanes
App 20120149674 - Chu; Lin ;   et al.
2012-06-14
Platelet-activating Factor Receptor Antagonists
App 20120108595 - Ogawa; Anthony ;   et al.
2012-05-03
Diaryl substituted alkanes
Grant 8,124,628 - Chu , et al. February 28, 2
2012-02-28
Biaryl Carboxamides
App 20110230498 - Ogawa; Anthony ;   et al.
2011-09-22
Benzimidazole And Aza-benzimidazole Carboxamides
App 20110207750 - Chu; Lin ;   et al.
2011-08-25
Diphenyl Substituted Alkanes as Flap Inhibitors
App 20110190346 - Chu; Lin ;   et al.
2011-08-04
Diphenyl Substituted Cycloalkanes
App 20110003815 - Ogawa; Anthony ;   et al.
2011-01-06
Diphenyl Substituted Alkanes
App 20100190761 - Ogawa; Anthony ;   et al.
2010-07-29
Diphenyl Substituted Alkanes
App 20100168076 - Ogawa; Anthony ;   et al.
2010-07-01
Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds And Methods Of Use
App 20100152185 - Chu; Lin ;   et al.
2010-06-17
Acylated piperidine derivatives as melanocortin-4 receptor agonists
Grant 7,700,778 - Goulet , et al. April 20, 2
2010-04-20
Anti-hypercholesterolemic compounds
Grant 7,696,177 - DeVita , et al. April 13, 2
2010-04-13
Anti-hypercholesterolemic compounds
App 20100004184 - De Vita; Robert J ;   et al.
2010-01-07
Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
Grant 7,629,467 - Chu , et al. December 8, 2
2009-12-08
Anti-hypercholesterolemic compounds
Grant 7,622,449 - Goulet , et al. November 24, 2
2009-11-24
Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis
App 20090258885 - Armstrong; Helen M. ;   et al.
2009-10-15
Diaryl Substituted Alkanes
App 20090258851 - Chu; LIN ;   et al.
2009-10-15
Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use
App 20090197883 - Armstrong; Helen M. ;   et al.
2009-08-06
Piperidine derivatives as melanocortin-4 receptor agonists
Grant 7,419,990 - Sings , et al. September 2, 2
2008-09-02
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
Grant 7,329,673 - Guo , et al. February 12, 2
2008-02-12
Diphenyl Substituted Alkanes as Flap Inhibitors
App 20070287736 - Chu; Lin ;   et al.
2007-12-13
Anti-hypercholesterolemic compounds
App 20070135357 - Sings; Heather L. ;   et al.
2007-06-14
Acylated piperazine derivatives as melanocortin-4 receptor agonists
Grant 7,160,886 - Bakshi , et al. January 9, 2
2007-01-09
Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
App 20060211677 - Chu; Lin ;   et al.
2006-09-21
Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
App 20060183904 - Guo; Liangqin ;   et al.
2006-08-17
Piperidine derivatives as melanocortin-4 receptor agonists
App 20060128963 - Sings; Heather ;   et al.
2006-06-15
Acylated piperidine derivatives as melanocortin-4 receptor agonists
Grant 7,015,235 - Goulet , et al. March 21, 2
2006-03-21
Acylated piperidine derivatives as melanocortin-4 receptor agonists
Grant 7,012,084 - Goulet , et al. March 14, 2
2006-03-14
Acylated piperidine derivatives as melanocortin-4 receptor agonists
App 20060035935 - Goulet; Mark T. ;   et al.
2006-02-16
Acylated piperidine derivatives as melanocortin-4 receptor agonists
App 20060025442 - Goulet; Mark T. ;   et al.
2006-02-02
Anti-hypercholesterolemic compounds
App 20050267049 - Goulet, Mark T. ;   et al.
2005-12-01
Acylated piperidine derivatives as melanocortin-4 receptor agonists
App 20040266821 - Ujjainwalla, Feroze ;   et al.
2004-12-30
Acylated piperidine derivatives as melanocortin-4 receptor agonists
Grant 6,818,658 - Ujjainwalla , et al. November 16, 2
2004-11-16
Acylated piperazine derivatives as melanocortin-4 receptor agonists
App 20040204398 - Bakshi, Raman K. ;   et al.
2004-10-14
Acylated piperidine derivatives as melanocortin-4 receptor agonists
App 20040097546 - Goulet, Mark T. ;   et al.
2004-05-20
Acylated piperidine derivatives as melanocortin-4 receptor agonists
App 20040092501 - Goulet, Mark T. ;   et al.
2004-05-13
Acylated piperidine derivatives as melanocortin-4 receptor agonists
App 20030225060 - Ujjainwalla, Feroze ;   et al.
2003-12-04
6-azaindole compounds as antagonists of gonadotropin releasing hormone
Grant 6,288,078 - Walsh , et al. September 11, 2
2001-09-11
Antagonists of gonadotropin releasing hormone
Grant 6,156,772 - Goulet , et al. December 5, 2
2000-12-05
Antagonists of gonadotropin releasing hormone
Grant 6,150,352 - Goulet , et al. November 21, 2
2000-11-21
Antagonists of gonadotropin releasing hormone
Grant 6,077,847 - Walsh , et al. June 20, 2
2000-06-20
Antagonists of gonadotropin releasing hormone
Grant 6,025,366 - Walsh , et al. February 15, 2
2000-02-15
Antagonists of gonadotropin releasing hormone
Grant 6,004,984 - Goulet , et al. December 21, 1
1999-12-21
Antagonists of gonadotropin releasing hormone
Grant 5,998,432 - Walsh , et al. December 7, 1
1999-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed